Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis
Clinical trial NCT04102241 · COMPLETED
Trial details
- NCT number
- NCT04102241
- Sponsor
- Tianjin Hemay Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-30
- Primary completion
- 2020-10-12
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.